Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis.
Saved in:
| Title: | Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis. |
|---|---|
| Authors: | Glicksman, R.M.1 (AUTHOR), Kishan, A.U.2 (AUTHOR), Katz, A.J.3 (AUTHOR), Mantz, C.A.4 (AUTHOR), Collins, S.P.5 (AUTHOR), Fuller, D.B.6 (AUTHOR), Steinberg, M.L.2 (AUTHOR), Shabsovich, D.2 (AUTHOR), Zhang, L.7 (AUTHOR), Loblaw, A.1,7,8 (AUTHOR) andrew.loblaw@sunnybrook.ca |
| Source: | Clinical Oncology. Jan2022, Vol. 34 Issue 1, p36-41. 6p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09366555 |
|---|---|
| DOI: | 10.1016/j.clon.2021.11.004 |
